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Abstract
Background: This study aimed to determine whether synchrotron radiation (SR)-based X-ray in-line phase-contrast
imaging (IL-PCI) can be used to investigate the morphological characteristics of tumor neovascularization in a liver
xenograft animal model.
Methods: A human hepatocellular carcinoma HCCLM3 xenograft model was established in nude mice. Xenografts
were sampled each week for 4 weeks and fixed to analyze tissue characteristics and neovascularization using
SR-based X-ray in-line phase contrast computed tomography (IL-XPCT) without any contrast agent.
Results: The effect of the energy level and object–to-detector distance on phase-contrast difference was in good
agreement with the theory of IL-PCI. Boundaries between the tumor and adjacent normal tissues at week 1 were clearly
observed in two-dimensional phase contrast projection imaging. A quantitative contrast difference was observed from
weeks 1 to 4. Moreover, 3D image reconstruction of hepatocellular carcinoma (HCC) samples showed blood vessels inside
the tumor were abnormal. The smallest blood vessels measured approximately 20 μm in diameter. The tumor
vascular density initially increased and then decreased gradually over time. The maximum tumor vascular density
was 4.29% at week 2.
Conclusion: IL-XPCT successfully acquired images of neovascularization in HCC xenografts in nude mice.
Keywords: Synchrotron radiation, In-line phase-contrast imaging, Computed tomography, Hepatocellular
carcinoma, Tumor neovascularization
Background
Neovascularization is an important feature of solid
tumors [1]. Evaluation of tumor neovascularization is
helpful for tumor diagnosis, prognosis and assessment of
anti-angiogenic efficacy. Vascular imaging techniques
including computed tomography angiography (CTA),
magnetic resonance angiography (MRA) and digital sub-
traction angiography (DSA) are based on the differences
in the vascular structures and blood flow between tumor
and normal vessels, and have been used to monitor
tumor angiogenesis or determine the efficacy of anti-
angiogenic therapies. However the spatial resolution,
especially when detecting small vessels with a diameter
of less than 200 μm is still limited [2, 3]. Even micro-
CTA, which has the highest resolution among these
methods, can only observe vessels of no less than 50 μm
in diameter [4, 5].
Synchrotron radiation (SR) microvascular angiography
combined with high-resolution and high-speed imaging
systems provide an effective approach to study tumor
angiogenesis. In vitro studies at the SPring-8 BL20B2
facility in Japan, using barium sulfate as a contrast agent,
have revealed the micro-vessel architecture of VX2
carcinoma specimens [6]. Using iodine as contrast agent,
SR micro-angiography reliably detects tumor micro-
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vessel density in vivo [7]. Neovascularization in Lewis
lung cancer tumor located deep inside the body was
observed using a three-dimensional reconstruction of
micro-CT imaging with barium sulfate as contrast agent
[8]. However, all these studies used absorption contrast
between the contrast medium and surrounding tissues.
Different from these attenuation-based X-ray imaging,
X-ray phase-contrast imaging (PCI) exploits differences
in the refractive index of different materials to differenti-
ate structures [9]. Thus, PCI can clearly define weakly
X-ray-absorptive biological soft tissues without the use
of a contrast agent. Several PCI modalities have been
developed, such as interferometry [10], diffraction
enhanced imaging (DEI) [11, 12], grating-based phase-
contrast X-ray imaging (GB-PCI) [13], and in-line phase
contrast imaging (IL-PCI) [14, 15]. Among them, IL-PCI
has no requirements of superior temporal coherence
within the X-ray source and complex experimental
apparatus in the light path. Synchrotron-based X-ray
Tomographic Microscopy (SRXTM) has been described
as a powerful technique for non-destructive high-
resolution investigations of various materials, allowing
micrometer and sub-micrometer, quantitative, three-
dimensional imaging; other techniques include the Swiss
Light Source TOMCAT, a new beamline for Tomographic
Microscopy and Coherent radiology experiments, which
offers sensitivity to density differentials within soft tissues
and permits the accommodation of larger tissue sizes
[16, 17]. Although studies are currently limited to the
stage of technique optimization with in vitro speci-
men analysis, SR-based X-ray in-line phase contrast
computed tomography (IL-XPCT) has great potential
for future clinical diagnostic application.
Using the third-generation synchrotron radiation light
source at the Shanghai Synchrotron Radiation Facility
(SSRF), IL-XPCT has achieved good results in micro-
vascular and tumor angiogenesis [18, 19]. The aim of the
present study was to investigate the morphological
characteristics of tumor neovascularization in a human




Male BALB/c athymic nude mice (5–6 weeks old, weigh-
ing 15–18 g) were purchased from SLAC Laboratory
Animal Co., Ltd. (Shanghai, China), and maintained
under specific pathogen-free (SPF) conditions at the
Animal Center of the Liver Cancer Institute of
Zhongshan Hospital affiliated to Fudan University
(Shanghai, China). All animal experiments were ap-
proved by the Animal Care and Use Committee of
Zhongshan Hospital, and were conducted in accordance
with all state regulations.
Cell culture
The HCCLM3 cell line was established by the Liver Cancer
Institute, Zhongshan Hospital, Fudan University, China, as
a HCC cell line with high metastatic potential. Cells were
maintained in high-glucose Dulbecco’s modified eagle
medium (D-MEM; GibcoBRL, Grand Island, New York,
USA) supplemented with 10% fetal bovine serum (Hyclone,
Utah, USA) in a humidified 5% CO2 atmosphere at 37 °C.
Orthotopic xenograft model
A single mouse was subcutaneously injected with 1 ×
107/0.2 ml HCCLM3 cells in the right upper flank region
for the establishment of a subcutaneous xenograft
model. When the subcutaneous tumor reached 1 cm in
diameter (approximately 4 weeks after injection), it was
removed, cut into small pieces of equal volume (1 mm3),
and transplanted into the left lobe of the liver of 24 nude
mice to establish orthotopic xenograft models, as previ-
ously described [20].
Preparation of liver samples
Each week after grafting, six nude mice were anesthe-
tized by intraperitoneal injection of sodium pentobar-
bital (0.016 g/mL, 0.5 mL/100 g). After opening the
abdominal cavity, a PE 10 catheter (Smiths Medical,
London, UK) was inserted into the inferior vena cava to
inject heparinized saline. When the liver looked pale, the
blood vessels and bile ducts were ligated, and the liver
was resected. Specimens were immersed in 4% formalde-
hyde for tissue fixation at room temperature overnight.
The next day, three samples were washed and dehy-
drated using graded ethanol for IL-PCI. Three other
samples were used for immunohistochemistry.
X-ray IL-PCI settings
Neovascularization imaging of tumor xenografts was
performed at the X-ray imaging and biomedical applica-
tion beamline (BL13W1) of the SSRF. The experimental
set-up is shown in Fig. 1. The SSRF BL13W1 imaging
device was a third-generation synchrotron source with a
200 mA beam current and 3.5 GeV storage energy. The
X-ray flux of BL13W1 was several orders of magnitude
of X-ray tube flux; the device was designed to provide
photon energy ranging from 8 to 72.5 keV with a beam
size of 48 mm (horizontal) × 5 mm (vertical) at the
object position at 20 keV. Objects are placed at approxi-
mately 34 m from the source (storage ring), and the de-
tector can be placed at 0 to 8 m from the objects. Based
on the sample size, a high resolution detector VHR 1:1
(Photonic Science, Roberts Bridge, East Sussex, UK) was
used with an effective pixel size of 9 μm. Because energy,
distance and image quality are not linearly correlated,
we used different X-ray energies (12, 15 and 20 keV) and
object-to-detector distances (0.05, 1, 3 and 5 m). The
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optimal X-ray energy and object-to-detector distance
were selected and used in subsequent experiments.
For the acquisition of CT images, the sample was rotated
180° at a speed of 0.25°/s, for a total of 1200 projection im-
ages. The exposure time of each projection image was 2s.
All projection images were transformed into digital slice
sections using the fast slice reconstruction software (com-
piled by the BL13W1 experimental station) based on the
filtered back projection (FBP) algorithm. Three-
dimensional reconstruction was obtained using the VG
Studio Max 3D reconstruction software (version 2.1,
Volume Graphics GmbH, Germany).
Image analysis
Phase contrast image evaluation
A normal hepatic lobe was taken for imaging at differ-
ent X-ray energy levels and object-to-detector dis-
tances. Four regions of interest (ROIs) and two internal
vessels (Fig. 2a) were selected in each frame to calculate
Fig. 1 The SSRF BL13W1 imaging device schematic diagram
Fig. 2 Method for calculating image contrast. a Four ROIs were labeled, and the two internal vessels were selected for calculating image contrast.
Vessel boundaries were identified using a computer software (Image Pro Plus 6.0) that can identify both edges of a vessel (b) by expressing a
density curve with a 256 gray-scale image (c)
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in which Imax and Imin represent the gray scale values on
either side of the blood vessel wall as determined using
the Image Pro Plus 6.0 software (Media Cybernetics Inc.,
Rockville, MD, USA; Fig. 2b, c).
Quantification of tumor neovascularization using two-
dimensional phase-contrast projection
Compared with surrounding normal liver tissues, the
tumor vessels are relatively smaller, with a low density,
resulting in different vascular boundary enhancements
in two-dimensional projection images. Based on this
principle, a two-dimensional phase-contrast image pro-
jection at different tumor growth stages was analyzed
using the Analyze 10.0 software (Analyze Direct, Inc.,
Lenexa, KS, USA). First, a threshold method was used to
correct the area with transmittance below a given value
to eliminate the impact of the suture inside the tumor.
To quantify the fluctuation of image intensities formed
in the detector plane, we used the following equation to
calculate the contrast projection, which is composed of
overlapping local contrasts [22]:
C x; yð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
< I x; yð Þ2>W− < I x; yð Þ >2W
q
< I x; yð Þ>W ð2Þ
In this formula, (x, y) represents a point in the image,
I is the intensity; subscript W denotes the size of the
local calculation window, and the operator < * > signifies
averaging over the local window.
Quantitative analysis of tumor neovascularization using
SR-based IL-XPCT
Tomographic images at different tumor growth stages
were analyzed using the Analyze 10.0 software. The
tumor was segmented manually in the tomographic
image to calculate tumor volume (mm3). A threshold
method was used to extract vessels from large quantities
of data. The smallest tumor vascular diameter (μm),
tumor neovascularization volume (mm3) and vascular
density (tumor neovascularization volume/tumor vol-
ume) were assessed [23].
Immunohistochemistry analysis of microvessel density
Tumor specimens were fixed in 4% formalin, embedded
in paraffin, and sliced into 4-μm-thick serial sections.
Slices were analyzed by hematoxylin-eosin (H&E) stain-
ing. Microvessel density (MVD) was determined by im-
munohistochemistry using an anti-CD34 antibody (C-18,
Santa Cruz Biotechnology Inc., USA). The number of
vessels was scored using a previously described method
[24] under a light microscope at 200 ×magnification.
Any single or cluster of cells with brown staining and
clearly separated from adjacent microvessels, tumor
cells, and other connective-tissue elements were counted
as a single microvessel.
Statistical analysis
Quantitative data were presented as mean ± standard
deviation (SD), except for MVD (non-normal distribu-
tion), which was expressed as median (interquartile
range [IQR]). Normally distributed data were analyzed
by repeated measures analysis of variance (ANOVA),
with post hoc Bonferroni t-tests. Simple linear regres-
sion models were used to assess the trend of the
changes of tumor development by analyzing tumor-
and vascular volumes (mm3) in relation to time. For
MVD, differences between samples were analyzed
using the Kruskal-Wallis test. All P-values were two
sided, and P < 0.05 was considered statistically signifi-
cant. Data were analyzed using SAS 9.2 (SAS Insti-
tute, Inc., Cary, NY, USA).
Results
Selection of imaging conditions
We first tested result quality using a normal liver sam-
ple. Figure 3a shows a normal liver lobe imaged at differ-
ent X-ray energy levels and object-to-detector distances.
Using an object-to-detector distance of 0.05 m, only
large branching vessels were visible with low contrast,
and the liver boundaries were obscure. At 15 keV, when
the distance was increased to 1 m, the progressive
branching of the liver vessels was visible, and the tiny
vessels at the outer edge of the liver lobe were clearly
displayed. However, images were slightly blurry when
the distance was increased from 3 to 5 m. Therefore,
the X-ray energy was set to 15 keV and the object-to-
detector distance at 1 m for the subsequent experi-
ments (Fig. 3b).
Tumor neovascularization using X-ray IL-PCI
The two-dimensional phase contrast projection imaging
showed that the normal liver vascular structures were
occupied by the tumor tissue (Fig. 4, 1w-a, 1w-b, 2w-a,
2w-b, 3w-a and 4w-a), with clear boundaries between
tumor and non-tumor tissues. Along with an increased
tumor volume, the tumor margin and peripheral vascu-
lature were under increased pressure, showing tissue
compression. The distribution of blood vessels within
the tumor was disorganized and had an irregular appear-
ance. In addition, the tumor presented a lobulated shape
as the tumor volume increased.
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Quantification analysis of the X-ray phase contrast im-
ages (Fig. 4, 1w-a, 1w-b, 2w-a, 2w-b, 3w-a and 4w-a)
using Eq. (2) showed significant differences in vascular
boundary enhancement effects at weeks 1 to 4, which
are represented by a higher contrast in the normal liver
tissue, and a relatively low contrast in tumor tissue
(Fig. 4,1w-c, 2w-c, 3w-b and 4w-b). Along with increas-
ing tumor volume, a large number of vessels at the
tumor margin were compressed. The vascular boundary
enhancement resulted in higher contrast (Fig. 4,4w-b). It
is noteworthy that the normal liver tissue presented as a
thin edge. Vascular boundary enhancement was lower in
these regions compared with thicker liver tissues near
the porta hepatis or close to liver tumor tissues, result-
ing in lower contrast (Fig. 4,3w-b and 4w-b).
Figure 5 presents a three-dimensional structural re-
construction of tumors at different growth stages. There
was much neovascularization at weeks 1 and 2 (Fig. 5a
and b), but the avascular regions gradually increased
thereafter (Fig. 5c and d). Vessels had an irregular shape
with partially visible dendritic branching (Fig. 5e). There
were abnormal curvatures of individual vessels, with
both large and small curvatures (Fig. 5f ). A vessel
network cluster structure was seen within the tumor at
weeks 3 and 4 (Fig. 5g). A large number of curved tiny
blood vessels branched from several large vessels
(Fig. 5h). Finally, tumor edge or peripheral vessels were
compressed, and presented as having arcuate displace-
ment (Fig. 5c, d).
Table 1 shows tumor volume, vascular volume and
vascular density at weeks 1 to 4. Tumor volume and vas-
cular volume increased with time, but the changes in
tumor volume were much greater than those in
tumor vascular volume. Although the number of new
vessels increased gradually, the tumor growth rate was
greater than the angiogenetic. Therefore, vascular dens-
ity first increased and then decreased during growth. At
week 2, tumors had the highest vascular density 4.29 ±
0.49%. The smallest blood vessels measured in SR im-
ages were approximately 20 μm in diameter. At different
stages of tumor growth, vessels of 27 to 54 μm in diam-
eter had the highest density.
We used gray scale analysis to monitor the influence
of ring artifact (Fig. 6). The gray intensity difference be-
tween the vessels and ring artifacts were close, and there
were no significant differences in phase contrast CT.
Therefore, the ring artifacts had a significant impact
on vascular identification during the vessel extrac-
tion process.
Micro-vessel density by immunohistochemistry
H&E staining and CD34 immunohistochemistry results
are shown in Fig. 7. The boundaries between tumor and
normal liver tissue could be shown clearly (Fig. 7a and b,
white arrows). CD34 expression was positive in the
abundant normal hepatic sinusoid (Fig. 7c and d, black
asterisks) and tumor angiogenesis (Fig. 7c to f, black
arrows and arrow heads). Tumor edge or peripheral
vasculature was compressed. Distribution of angiogenesis
was disordered within the tumor. The micro vascular-rich
regions were diffusely distributed at the edge of tumor
nests. Neovascularization with different diameters was
seen, and abnormal large vessels (Fig. 7e and f, black
arrow heads) and slit-like small vessels (Fig. 7c to f, black
arrows) coexisted. The characteristics of vascular arrange-
ments in PCI images were partly similar with that of histo-
logical sections. In addition, necrosis could be seen in
tumor nests (Fig. 7c and d, white asterisks).
Fig. 3 Two-dimensional projection images vs. hepatic vascular
phase contrast at different X-ray energies and object-to-detector
distances. a Normal liver lobe with X-rays set to 12, 15 and 20 keV. Each
energy condition was used at 0.05, 1, 3 and 5 m. Bar = 1 mm. b Quantitative
comparison of image contrast at different X-ray energy levels and object-to-
detector distances. The best image contrast was obtained using
15 keV and at 1 m
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The MVD based on CD34 expression at weeks 1 to 4
was 25 (12–35) vessels/high-powered field (HPF), 16.5
(15–20) vessels/HPF, 29 (16–40) vessels/HPF, and 20
(15–25) vessels/HPF, respectively. There were no sig-
nificant differences in MVD values between time
points (P = 0.758).
Discussion
Neovascularization reflects tumor behavior and charac-
teristics, and has received much attention in recent years
[25, 26]. PCI displays a high sensitivity for soft tissues
such as blood vessels [4, 15, 19, 27, 28]. In the present
study, the neovascularization of transplanted HCCLM3
tumors was imaged at different growth stages, and
morphology and spatial distribution of tumor angiogen-
esis were observed.
For IL-PCI, the X-ray energy and the distance from
object to detector are two important parameters [8, 9, 29].
Indeed, the lower the energy, the higher the contrast.
However, low energy reduces X-ray penetration, extends
Fig. 4 Two-dimensional phase contrast projection imaging of HCCLM3 liver xenografts at weeks 1 to 4. 1w-b and 2w-b are magnified images of
the boxed regions in 1w-a and 2w-a, respectively. The red arrows indicate the margins of the tumor, in which the normal hepatic vascular struc-
ture was damaged and replaced. The dark region is the shadow from the suture. The vascular boundary enhancement in the tumor region was
detected as low contrast in the quantitative analysis results (1w-c, 2w-c, 3w-b, 4w-b). Normal liver tissue presented as a thin edge with low con-
trast, close to the tumor tissue (3w-b, 4w-b)
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Fig. 5 3D reconstruction of contrast CT images for HCC neovascularization at weeks 1 to 4 (a to d, respectively). The selected areas with red dot lines
show the tumor regions, (e to f) enlarged image of the rectangle region of d, which clearly shows the disorganized distribution and morphology of
tumor neovascularization. A large number of avascular regions were observed in the tumors at weeks 3 and 4 (c, d), as well as irregular vessel shape
with dendritic-like branching (e), individual vascular curvature abnormalities (f), blood vessel network cluster structure (g), a large number of tiny and
curved vessels derived from a few thick vessels (h, red arrows), and compressed tumor edge or peripheral vasculature (c, d)
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imaging time, and increases the radiation dose. Thus, the
energy level should be selected according to the specific
target object in order to balance contrast and radiation
dose. Based on Fresnel’s diffraction theory of wave optics,
the object-to-detector distance is zero in traditional
absorption imaging. However, phase-contrast images are
formed with greater distances from the object. The visual
appearance of phase-contrast enhancement in the final
image is the edge enhancement at interfaces between
components with differing X-ray refraction indices.
Increasing object-to-detector distance leads to phase con-
trast enhancement, which is affected by the interference
between the sample and X-rays; however, a distance
beyond a certain range causes decreased spatial resolution,
with the image losing resemblance [9]. Also, PCI details
increase with time, because prolonged exposure to air and
heat from the X-rays gradually dehydrates the samples
[21, 30]. In addition, specimen thickness, the fixation
method, and exposure time are important factors affecting
image quality [21, 30]. According to the sample size and
thickness, a CCD detector with a resolution of 9 μm was
selected, the X-ray energy was set to 15 keV, and the dis-
tance from source to detector was 1 m. Based on the
principle that the image occupies the whole dynamic
range without saturation, we selected the appropriate
exposure time and obtained a satisfactory edge enhance-
ment effect using IL-PCI.
Based on the differences in vascular edge enhancement
between tumors and adjacent normal liver tissues,
quantitative analysis of the X-ray phase contrast images
showed a higher contrast in the normal liver tissue, and
a relatively lower contrast in tumor tissues. However, the
calculation method used in this study is affected by
many factors, including tissue thickness and the signal-
to-noise ratio [22].
IL-XPCT is suitable for the detailed 3D morphological
imaging of small structure [27, 31–33]. As shown above,
differences were found in tumor vascular density at dif-
ferent growth stages. Tumor vascular density first in-
creased and then decreased over time. This may be
related to the highly malignant ability of the HCCLM3
cell line used in the present study. At the late stage of
tumor growth, tumor cells multiply quickly, leading to
inadequate nutrient supply and abundant tumor necro-
sis. In addition, the smallest distinguishable tumor vessel
diameter was found to be 20 μm.
Currently, immunohistochemistry is considered the
“gold standard” for measuring MVD [24]. However,
no significant difference in MVD was found in this
study during the four weeks; this may be due to the
small sample size. In addition, immunohistochemistry
only reveals the two-dimensional distribution of blood
vessels, and the observer selectively counts the tumor
vessels in the “hot zone”. Therefore, immunohisto-
chemistry may not reflect the morphology and spatial
distribution of tumor angiogenesis, resulting in the
loss of potentially critical information about the
vascular structure.
Table 1 Characteristics of the HCCLM3 liver xenografts at different time points
n Time points Linear regression
coefficient
P-value
Week 1 Week 2 Week 3 Week 4
Tumor volume (mm3) 3 3.78 ± 0.44 27.97 ± 7.33 129.27 ± 23.06 409.10 ± 33.71 0.91993 <0.001
Vascular volume (mm3) 3 0.13 ± 0.02 1.18 ± 0.23 3.33 ± 0.25 6.17 ± 0.35 0.97726 <0.001
Vascular density (%) 3 3.51 ± 0.14 4.29 ± 0.49 2.62 ± 0.29 1.52 ± 0.15 — 0.5784
Data are presented as mean ± standard deviation (SD)
Fig. 6 Gray scale analysis of vessels and ring artifacts using two-dimensional PCI tomographic imaging. Left: The gray scale analytical measure-
ment ranges of vessels and ring artifacts is indicated in red and black. Right: The vertical axis in the graph is gray intensity, the abscissa is pixel
number, labeling the corresponding pixel position of each gray value. Gray scale values between vessels and ring artifacts were similar, with no
statistically significant differences
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However, phase-contrast CT imaging is more challen-
ging in tumor angiogenesis imaging and quantitative
calculations than absorption-contrast CT. Indeed, phase-
contrast CT suffers from ring artifacts: the gray value
difference between the vessel and ring artifacts is small,
rendering difficult the threshold setting of vascular
segmentation in CT images and interfering with blood
vessel identification. If the set threshold is too low, ring
artifacts may be classified as vessels, thereby over-
evaluating the vessel density. If it is too high, actual
vessel density will be underestimated. Future studies
should be carry out to remove ring artifacts and improve
the ability to identify vessels. During tumor growth, both
necrotic tissue and tiny vessels were similarly gray.
Therefore, it was difficult to distinguish between the two
entities. Thus, vascular density in vessel segmentation
may be overestimated. Finally, hand-drawing of the
tumor region was subjective, as was the selection of the
areas by different observers.
The present study had some limitations. First, a 9 μm
CCD detector was chosen considering sample size and
thickness; therefore, the smallest vessel diameter de-
tected was approximately 20 μm. Since the capillary
diameter varies from a few to a hundred μm, vessels of
less than 20 μm were not observed and tumor vascular
density could be underestimated. Therefore, we will use
higher-resolution detectors in future studies. Second, the
X-ray energy and object-to-detector distance were se-
lected based on in vitro experiments. Finally, the im-
aging results were acquired from ethanol-dehydrated,
formalin-fixed specimens. As a pioneer imaging technique,
SR-based IL-XPCT, mainly limited by small beam size and
Fig. 7 Histopathological images of HCCLM3 orthotopic xenograft tumors at 2 weeks. Left: H&E staining. Right: CD34 immunohistochemistry. a b
Histopathological images of cancer tissues at week 2. Scale bar = 1 mm. c d Histopathological images of cancer tissues at week 2. Bar = 200 μm. e
f Histopathological images of cancer tissues at week 3. Bar = 200 μm. The boundaries between tumor and normal liver tissue could be shown
clearly (a and b, white arrow). CD34 expression was positive in the abundant normal hepatic sinusoid (c and d, black asterisks) and tumor
angiogenesis (c to f, black arrows and arrow heads). The tumor edge or peripheral vasculature was compressed, having a shift in its curvature. The
microvascular-rich regions were diffusely distributed at the edge of tumor nests. New vessels with different diameters were seen. The abnormal
large vessels (e and f, black arrow heads) and slit-like small vessels (c to f, black arrows) coexisted. The characteristics of the vascular arrangements
in PCI images were partly similar with those of histological sections. In addition, necrosis could be seen in the tumor nest (c and d, white asterisks).
The MVD of CD34 expression in tumors was determined by immunohistochemistry. Data are shown as median (Q25, Q75)
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high radiation dose, still needs further optimization to suit
clinical application. Even in vivo imaging of neovasculariza-
tion remains a challenging task. Therefore, the currently
available studies mainly concentrate on in vitro specimen
imaging to optimize the settings as well as to find the po-
tential application field. In the future, provided that the
problems related to technical facilities, imaging parameters
and experimental model preparation are resolved, in vivo
application of IL-XPCT is promising. Optionally, combin-
ing GB-PCI with conventional X-ray tube may be applic-
able in clinical conditions. Future studies should also
examine bone samples from bone tumors or metastatic
bone lesions using IL-XPCT, comparing the results with
existing micro-CT data for such specimens.
Conclusion
In this study, we demonstrated that SR-based IL-
XPCT successfully acquires images of neovasculariza-
tion in liver tumor xenografts. This technique can
distinguish tumors from the normal liver tissue, and
detect blood vessels as small as 20 μm in diameter.
In addition, quantitative analysis showed that vascular
density increases first and then decreases gradually
with tumor growth.
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